Merck global human health president
GE Healthcare Bio-Sciences CEO Peter Loescher becomes Merck's first global human health president effective May 1. Loescher will oversee the company's sales and marketing divisions - U.S. Human Health, Human Health Asia Pacific, Human Health Intercontinental and Merck Vaccines - which previously reported directly to CEO Richard Clark. The global human health president position, created as part of the company's sales restructuring announced in December, is intended to produce greater continuity for customers across different markets (1"The Pink Sheet" Dec. 19, 2005, p. 3)...
You may also be interested in...
Merck's restructuring program is shifting selling and marketing resources away from physician detailing towards payer and patient promotion, CEO Richard Clark indicated during the firm's annual business review in Whitehouse Station, N.J
Sponsors want more endpoint clarity as current state of government pandemic response, along with scientific and regulatory hurdles, is constraining efforts to refill a shrinking COVID medicine cabinet and could create vulnerabilities for future pandemics.
Beijing’s latest proposal to ban gene editing is viewed as a direct response to Washington’s tightening grip over the transfer of US technology to China.